SEC Form 4 · accession 0001213900-18-005374

NEXEON MEDSYSTEMS INC · NXNN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 31, 2017

Accepted (ET)

May 1, 2018 · 8:12 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001416172

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
OPTIONS^F1	$1.80	Dec 31, 2017	A	12,500	A	Dec 31, 2017	Dec 31, 2021	COMMON STOCK	12,500	12,500	D
OPTIONS^F2	$0.87	Mar 31, 2018	A	12,500	A	Mar 31, 2018	Mar 31, 2022	COMMON STOCK	12,500	12,500	D

F1On December 31, 2017 and pursuant to Reporting Person's appointment as Director, the Issuer granted to Reporting Person an option (the "December Option") to purchase 12,500 shares of the Issuer's restricted common stock, at a price of $1.80 per share. The term of each December Option shall be for a period of four (4) years from the date of issue. The fair value of the December Option was determined to be $7,534 using the Black-Sholes Option Pricing Model. The December Option was immediately exercisable at date of issue.
F2On March 31, 2018 and pursuant to Reporting Person's appointment as Director, the Issuer granted to Reporting Person an option (the "March Option") to purchase 12,500 shares of the Issuer's restricted common stock, at a price of $0.87 per share. The term of each March Option shall be for a period of four (4) years from the date of issue. The fair value of the March Option was determined to be $3,596 using the Black-Sholes Option Pricing Model. The March Option was immediately exercisable at date of issue.